Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 155 | nsp16:G155-; | CL-3e; |
| 155 | nsp16:G155R; | CL-3e; |
| 164 | nsp16:G164E; | CL-3d; |
| 164 | nsp16:G164H; | CL-1a_3d;CL-3d; |
| 165 | nsp16:G165C; | CL-3b;CL-3d;CL-3e; |
| 185 | nsp16:G185E; | CL-3b;CL-3d;CL-3e; |
| 208 | nsp16:G208-; | CL-3b; |
| 208 | nsp16:G208R; | CL-2; |
| 213 | nsp16:G213-; | CL-3b;CL-3e; |
| 213 | nsp16:G213D; | CL-2;CL-3b;CL-3e; |
| 213 | nsp16:G213N; | CL-3b;CL-3d;CL-3e;CL-3f; |
| 213 | nsp16:G213S; | CL-3b; |
| 256 | nsp16:G256S; | CL-3e; |
| 265 | nsp16:G265-; | CL-3e; |
| 265 | nsp16:G265C; | CL-3c; |
| 265 | nsp16:G265D; | CL-2; |
| 278 | nsp16:G278-; | CL-3c; |
| 278 | nsp16:G278S; | CL-1a; |
| 31 | nsp16:G31-; | CL-3c; |
| 31 | nsp16:G31D; | CL-3e; |
| 31 | nsp16:G31S; | CL-3d; |
| 31 | nsp16:G31V; | CL-3e; |
| 39 | nsp16:G39-; | CL-3a; |
| 39 | nsp16:G39C; | CL-3b;CL-3e; |
| 39 | nsp16:G39D; | CL-3d;CL-3e; |
| 77 | nsp16:G77V; | CL-3e; |
| 81 | nsp16:G81-; | CL-3b; |
| 92 | nsp16:G92-; | CL-3b; |
| 92 | nsp16:G92C; | CL-3e; |
| 92 | nsp16:G92D; | CL-3d; |
| 119 | nsp16:H119-; | CL-3e;CL-3f; |
| 119 | nsp16:H119R; | CL-3d; |
| 174 | nsp16:H174-; | CL-3e; |
| 174 | nsp16:H174Y; | CL-3c;CL-3e;CL-3f; |
| 186 | nsp16:H186Q; | CL-3b; |
| 186 | nsp16:H186R; | CL-3e; |
| 225 | nsp16:H225-; | CL-3b; |
| 69 | nsp16:H69-; | CL-3e; |
| 112 | nsp16:I112T; | CL-3a; |
| 127 | nsp16:I127V; | CL-3b;CL-3d; |
| 128 | nsp16:I128-; | CL-3b; |
| 128 | nsp16:I128M; | CL-3f; |
| 128 | nsp16:I128V; | CL-1a;CL-3b;CL-3e; |
| 157 | nsp16:I157T; | CL-3e; |
| 169 | nsp16:I169-; | CL-3e; |
| 169 | nsp16:I169M; | CL-1a_3c;CL-3f; |
| 169 | nsp16:I169V; | CL-3c;CL-3e;CL-3f; |
| 171 | nsp16:I171-; | CL-3b;CL-3e; |
| 171 | nsp16:I171V; | CL-3e; |
| 219 | nsp16:I219M; | CL-3d;CL-3e; |
Page 215 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com